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 genome analysis and did not detect any 
significant changes. Fluorescence  in situ 
hybridization of MSCs isolated from fi ve 
controls and three renal failure patients indi-
cated that more than 95 % of the cells had a 
normal karyotype. However, a small number 
of tetraploid cells were detected after 
ten population doublings, an amount of 
expansion that is oft en required to obtain 
a sufficient number of cells for clinical 
applications. 
 The studies by Roemeling-van Rhijn 
 et al. 3 demonstrated that the phenotype of 
adipose tissue – derived MSCs isolated from 
renal failure patients and control subjects 
is similar. While maintaining enthusiasm 
in using our own fat-tissue-derived MSCs 
for potential treatment of kidney disease, 
it is critical that we perform thorough test-
ing in animal models before conducting 
human studies and continue long-term 
monitoring for safety and effi  cacy. 
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 Interaction of receptor for 
advanced glycation end products 
with advanced oxidation protein 
products induces podocyte injury 
 Yasuhiko  Yamamoto 1 and  Hiroshi  Yamamoto 1 
 Chronic kidney disease (CKD) is characterized by progressive decline in 
renal function. Podocyte dropouts contribute to the pathogenesis of 
diabetic and nondiabetic CKD. Zhou and colleagues demonstrate that 
the association between advanced oxidation protein products (AOPPs) 
and receptor for advanced glycation end products (RAGE) elicited 
podocyte injuries, using cultured podocytes and mice injected with 
AOPPs. This study suggests that the blockade of RAGE is preventive 
and therapeutic against podocyte apoptosis caused by oxidative 
stress-related AOPPs in CKD. 
 Kidney International (2012)  82, 733 – 735.  doi: 10.1038/ki.2012.163 
 Chronic kidney disease (CKD) is a world-
wide health problem, with a rapidly 
increasing prevalence. Podocyte dysfunc-
tions, including podocyte loss and slit 
diaphragm disruptions, are closely linked 
to the pathogenesis of CKD. 1 Progressive 
kidney disease leading to end-stage renal 
disease is characterized by the progression 
of glomerulosclerosis and interstitial 
fi brosis. Th e common critical pathways 
could be involved in almost all forms of 
CKD. Th erefore, exploring the factors that 
can activate the pathways is important for 
the development of new strategies to pre-
vent and attenuate the development of 
CKD. The numerous factors that have 
been implicated in the initiation of the 
cascades include angiotensin II, growth 
factors, cytokines, oxidative and nitrosa-
tive stress, endoplasmic reticulum stress, 
mechanical stress, advanced glycation end 
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products (AGEs), and advanced oxidation 
protein products (AOPPs). AGEs are 
products of non-enzymatic glycation and 
oxidation of proteins and lipids, and AGE 
formation increases in situations with 
hyperglycemia and oxidative stress, such 
as diabetes mellitus. Recent clinical stud-
ies demonstrated that AOPPs are closely 
related to the initiation and progression of 
renal dysfunction in patients with a vari-
ety of diabetic and nondiabetic CKD. 2 In 
experimental animal studies, chronic 
administration of AOPPs accelerated 
renal fi brosis and deteriorated renal dys-
function. 2 AOPPs are thus considered 
causative factors in CKD. 
 Witko-Sarsat and colleagues 3 fi rst des-
ignated and described AOPPs in 1996. 
AOPPs abundantly contain dityrosines, 
which allow cross-linking through 
disulfi de bridges and carbonyl groups. 
AOPPs are formed mainly from chlorin-
ated oxidants, such as hypochloric acid 
and chloramines, partly through catalysis 
by myeloperoxidase. Neutrophils use the 
myeloperoxidase – H 2 O 2 – chloride system 
and form AOPPs and AGEs, such as  N    -
carboxymethyl-lysine and glycolaldehyde-
pyridine. 4 Characteristic chemical 
structures of heterogeneous AOPPs need 
see original article on page 759
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to be clarifi ed. AOPPs have several physico-
chemical characteristics similar to those 
of AGEs. Apart from the common mech-
anism of formation leading to protein 
damages, they share some biological 
eff ects as well, including interaction with 
RAGE. 5,6 
 Th e receptor for AGEs (RAGE), origi-
nally isolated as an AGE-binding receptor, 
belongs to the immunoglobulin super-
family and is now recognized as a member 
of the pattern-recognition receptors and 
a proinflammatory molecular device. 7 
Endogenous and exogenous RAGE lig-
ands other than AGEs and AOPPs have 
been reported, including high-mobility 
group box protein 1 (HMGB1), the cal-
cium-binding S100 protein group,   2 -
integrin Mac / CD11b, amyloid   peptide, 
  -sheet fi brils, complement C3a, lipopol-
ysaccharides, and phosphatidylserine on 
the surface of apoptotic cells 7 ( Figure 1 ). 
Th e ligand engagement of RAGE activates 
nuclear factor-  B and other signaling 
pathways via the stimulation of extracel-
lular signal-regulated kinase 1 / 2, p38 
mitogen-activated protein kinase – c-Jun 
N-terminal kinase, Janus kinase – signal 
transducer and activator of transcription, 
protein kinase C, and Rac – Cdc42. 7 Th e 
ligation of RAGE leads to a positive feed-
forward loop in which inflammatory 
stimuli activate nuclear factor-  B, which 
induces RAGE expression, followed again 
by nuclear factor-  B activation. TIRAP 
(toll / interleukin-1 receptor domain-con-
taining adaptor protein) and MyD88, 
which are adaptor proteins for toll-like 
receptors (TLRs) 2 and 4, bind to phos-
phorylated RAGE and transduce the 
signal to downstream molecules. 8 Th is 
suggests a functional interaction between 
RAGE and TLRs, as well as the regulation 
of immune responses and infl ammation 
in a coordinated fashion. 
 Zhou and colleagues 9 (this issue) report 
that interactions between AOPPs and 
RAGE elicited podocyte injuries, with 
less effect of the association of AOPPs 
with scavenger receptors class BI (SR-BI) 
and CD36, known as the receptor in 
other cell types. AOPP-mediated cellular 
derangements have already been reported 
in endothelial and mesangial cells. Direct 
physical association and the binding affi  n-
ity of AOPPs with RAGE need to be clari-
fi ed. Zhou and colleagues describe that 
the AOPP preparations used in the study 
did not contain AGE components, such as 
 N    -carboxymethyl-lysine, pentosidine, 
pyridine, and glyoxal-, glycolaldehyde-, 
and glyceraldehyde-derived AGEs, sug-
gesting that the observed eff ects were not 
associated with AGE-like structures. 9 
 Endogenous secretory RAGE (esRAGE) 
is a major splice variant of RAGE and is 
expressed in a wide variety of cell types. 10 
Th e cleavage of the membrane-bound, 
full-length signal-transducing RAGE 
yields soluble RAGE (sRAGE). 10 esRAGE 
and sRAGE are thought to act locally and 
systemically as decoy receptors. It is inter-
esting to evaluate the expression of full-
length RAGE and esRAGE / sRAGE and to 
induce the esRAGE production and ecto-
domain shedding of full-length RAGE in 
podocytes. 
 In summary, suppression of RAGE 
action may be benefi cial for preventing 
and retarding the development of CKD. 
Future studies should focus on developing 
new devices and remedies for targeting 
RAGE in podocytes. 
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 Figure 1  |  Possible participation of the pattern-recognition receptor RAGE and its multiple 
ligands in the development of chronic kidney disease. AGE, advanced glycation end products; 
AOPP, advanced oxidation protein products; ERK, extracellular signal-regulated kinase; HMGB1, 
high-mobility group box protein 1; JAK-STAT, Janus kinase – signal transducers and activators of 
transcription; LPS, lipopolysaccharides; mDia-1, mammalian diaphanous-related formin-1; NF-  B, 
nuclear factor-  B; PKC-  , protein kinase C-  ; PS, phosphatidylserine; Rac / Cdc42, Rac / cell division 
control protein 42 homolog; RAGE, receptor for AGEs; Ras / MAPK, Ras / mitogen-activated protein 
kinase; ROS, reactive oxygen species. 
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 The mitochondrial SIRT1 – PGC-
1  axis in podocyte injury 
 Shuichi  Tsuruoka 1 ,  Akira  Hiwatashi 1 ,  Joichi  Usui 1 and  
 Kunihiro  Yamagata 1 
 Dysfunction of mitochondria in podocytes is believed to be a trigger 
of injury and contributes to progressive glomerular sclerosis; however, 
the mechanisms had not been fully understood. Yuan  et al. report 
involvement of SIRT1 (a homolog of the life-extending gene  sir2 
in mammals) and PPAR-  coactivator 1  , a major regulator of oxidative 
metabolism, in mitochondria during podocyte injury. This information 
will be important in exploration of the mechanisms and future 
treatment of glomerular sclerosis. 
 Kidney International (2012)  82, 735 – 736.  doi: 10.1038/ki.2012.182 
 Th e podocyte is one of the components 
of the glomerular fi ltration barrier and 
serves to prevent filtration of protein 
from the blood. Th is cell is terminally dif-
ferentiated and highly specialized. Mature 
podocytes have limited ability to prolifer-
ate following injury, linked to high 
expression of the cyclin-dependent 
kinase inhibitors, which appear to be 
rate-limiting for podocytes to reenter 
the cell cycle. 1 Podocyte injury causes 
detachment of the cell from the barrier. 
Once podocytes have detached from the 
glomerular basement membrane (GBM), 
the exposed outer surface of the GBM 
adheres to the inner surface of the 
Bowman ’ s capsule, and a focal segmental 
glomerulosclerosis (FSGS) lesion is 
established. 1 This series of changes is 
commonly seen in various types of 
glomerular disease and causes progres-
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sion of chronic kidney disease. Th e mecha-
nisms of the injury of this cell are not 
fully understood; however, several mecha-
nisms, such as peroxisome proliferator-
activated receptor-  (PPAR-  )-mediated 
apoptosis and increase of reactive oxygen 
species, were reported in an animal model 
of puromycin aminonucleoside nephrosis 
with FSGS. 1 
 Mitochondria are essential intracellular 
organelles that have a major role in energy 
production by adenosine triphosphate 
(ATP) synthesis through oxidative phos-
phorylation. Each mitochondrion has its 
own DNA, which is the only extranuclear 
genome in eukaryotes. Mitochondrial 
DNA (mtDNA) is prone to oxidative 
stress, as it apparently lacks histone-like 
coverage and is localized closely to the 
inner mitochondrial membrane, a major 
site of reactive oxygen species in cells. 2 
Mitochondrial dysfunction causes various 
types of diseases, such as myopathy 
and encephalopathy. 3 With regard to the 
kidney, mitochondrial dysfunction was 
reported mainly in tubular cells. For exam-
ple, acute kidney injury by various toxins 
and hypoxia causes the dysfunction 
of mitochondria in proximal tubular 
cells. 1,4 Although FSGS developed in 
children with mitochondrial cytopathies, 5 
information about mitochondrial dys-
function in glomerular disease was still 
limited. In a rat model of puromycin 
aminonucleoside nephrosis with FSGS, 
reduction of mtDNA copy number in 
podocytes was reported. 2 Th erefore, podo-
cyte injury was triggered by mitochondrial 
dysfunction due to mtDNA depletion of 
the cell, which led to glomerular sclerosis, 
perhaps via an increase of oxidative stress 
and a relative shortage of ATP synthesis 
resulting from the energy demand of the 
podocyte; however, the mechanisms were 
not fully understood. 
 It was previously reported that PPAR-  
coactivator 1  (PGC-1  ), a transcriptional 
activator of PPAR-  , is a major regulator of 
mitochondrial oxidative metabolism, which 
specifi cally binds to the mitochondrial tran-
scription factor A (TFAM) promoter, a 
direct regulator of mtDNA replication in 
non-kidney cells. 1,6 It was also recently 
reported that SIRT1 (silent mating type 
information regulation 2 homolog 1, a 
homolog of the life-extending gene  sir2 in 
mammals) regulates PGC-1  activity and 
energy metabolism of mitochondria by 
its deacetylation in different tissues. 7 
With regard to the kidney, modifi cation 
of cisplatin-induced acute kidney injury 
by transgenic overexpression of SIRT1 in 
S1- and S2-segment proximal tubules 
was reported. 8 It was also reported that 
calorie restriction enhances cell adaptation 
to hypoxia through SIRT1-dependent 
mitochondrial autophagy in mouse renal 
tubules. 9 
 Yuan  et al. 10 (this issue) report several 
lines of evidence that the activation of 
the SIRT1 – PGC-1  axis in mitochondria 
ameliorates aldosterone-induced podo-
cyte injury  in vitro and  in vivo . They 
found that aldosterone suppressed 
SIRT1 – PGC-1  activation in the cultured 
podocytes. They further showed that 
overexpression of SIRT1 or PGC-1  inhi-
bited the aldosterone-induced mitochon-
drial dysfunction and podocyte injury. 
Resveratrol, an activator of SIRT1, pro-
tected mitochondrial function against 
podocyte injury in aldosterone-treated 
mice. Th e authors also showed that podo-
cyte injury by aldosterone was mediated 
